Immunological lessons learnt from patients transplanted with fully mismatched stem cells.

Area of Science:

• Immunology
• Transplantation Biology
• Pediatric Hematology

Background:

• Severe combined immunodeficiency disease (SCID) necessitates immune reconstitution.
• Hematopoietic stem cell transplantation (HSCT) is a primary treatment for SCID.
• Fully HLA-mismatched transplants present unique immunological challenges.

Purpose of the Study:

• To evaluate the efficacy and immunological outcomes of fully HLA-mismatched fetal liver stem cell transplantation in SCID patients.
• To investigate T-cell and B-cell function, and immune tolerance development in HLA-mismatched chimeras.

Main Methods:

• Transplantation of human fetal liver stem cells into infants and fetuses with SCID.
• Longitudinal immunological monitoring of engraftment, immune reconstitution, and cellular functions.
• Analysis of T-cell and B-cell origins and their interactions in HLA-mismatched chimeras.

Main Results:

• Successful donor cell engraftment and immune reconstitution in 14/19 patients.
• Donor T-cells coexisted with host B-cells and antigen-presenting cells (APCs) without major functional deficits.
• Effective anti-pathogen responses and cytotoxic T-cell activity were observed despite HLA disparities.
• Antigen recognition occurred via host allogeneic HLA presentation, not self-HLA.
• Acquired tolerance to donor antigens (clonal deletion) and host antigens (clonal anergy) was established.

Conclusions:

• Fully HLA-mismatched fetal liver stem cell transplantation can achieve successful immune reconstitution in SCID.
• Donor T-cells can effectively function in a host environment with mismatched B-cells and APCs.
• The study demonstrates novel mechanisms of immune tolerance and antigen recognition in HLA-mismatched chimeras.